Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Feb 24, 2023 4:34pm
103 Views
Post# 35304449

RE:RE:RE:RE:RE:RE:"Nearing 90 patient interim enrollment"

RE:RE:RE:RE:RE:RE:"Nearing 90 patient interim enrollment"

Concerns should be brought forward to members of the BoD - as I have done...and you should as well.

Negative discussion on BB will NOT drive change in the C-suite, and can only serve to frighten new investors away (maybe the plan?).  But I doubt that with near zero effective IR/promotion, there are many newbies lurking anyway.  The best candidates (and in much greater numbers) are south of the border where we have almost zero visibilty (OMG, the pumper just gave another oft repeated criticism)

Tigris enrolment pace = dirty bathwater. PMX = the baby.

Throwing the baby out with the bathwater is stupidity.  Look at the big picture and ask yourself what can I do to change the situation...unless the status quo is what you really want.

MM
<< Previous
Bullboard Posts
Next >>